Scott W. Morrison - 06 Oct 2022 Form 3 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role: Director
Signature: /s/ Leonard M. Greenstein, Attorney-in-Fact
Issuer symbol: TARS
Transactions as of: 06 Oct 2022
Net transactions value: $0
Form type: 3
Filing time: 11 Oct 2022, 16:20:18 UTC
Previous filing: 06 Oct 2022
Next filing: 12 May 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney